Market Cap$23.15B
P/E—
PEG Ratio2.21
Div yield4.34%
Beta0.90
IFF Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)15.02%
Price vs S&P 500 (4W)9.79%
PEG Ratio2.21
VGM Score52.69
Indicated Dividend Yield (Annual)4.34%
IFF Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.12 | $0.82 | -26.57%(-$0.30) | |
| Q1 2026 | $1.07 | $1.25 | +16.51%(+$0.18) | |
| Q4 2025 | $0.83 | $0.80 | -3.81%(-$0.03) | |
| Q3 2025 | $1.02 | $1.05 | +3.32%(+$0.03) | |
| Q2 2025 | $1.12 | $1.15 | +2.53%(+$0.03) |
IFF Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.95
4.04
4.04
4.00
Industry Peers — Industrial Chemicals(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
IFFInternational Flavors & Fragrances Inc. | C | D | A | 2.3x | -11.7% | 37.5% | — | $90.68 |
| LYBLyondellBasell Industries N.V. Class A | B | D | A | 0.7x | -11.3% | 12.8% | -15.3% | $64.01 |
| WLKWestlake Corporation | B | C | C | 0.7x | -4.0% | 9.6% | 7.3% | $63.33 |
| NEUNewMarket Corporation | C | C | B | 2.9x | -1.3% | 31.5% | 12.6% | $876.01 |
| SXTSensient Technology Corporation | D | C | A | 3.3x | 8.1% | 34.9% | 4.0% | $133.74 |
| MEOHMethanex Corp | B | B | A | 1.2x | 19.3% | 28.6% | 16.2% | $64.96 |
| REXREX American Resources Corp. | B | B | B | 2.0x | 5.3% | 21.5% | 72.8% | $41.72 |
| GPREGreen Plains, Inc. | B | D | B | 0.6x | -23.7% | 16.0% | — | $14.47 |
| WLKPWESTLAKE CHEMICAL PARTNERS LP | A | C | B | 0.6x | 12.1% | 31.2% | -6.0% | $20.80 |
| BAKBraskem S.A. American Depositary Shares (Each representing Two Class A Preferred Shares) | C | D | D | 0.0x | -31.1% | 8.9% | — | $1.66 |
| GEVOGevo, Inc. | B | B | D | 1.6x | 121.4% | 47.4% | — | $1.17 |
About International Flavors & Fragrances Inc.
International Flavors & Fragrances is the world's largest specialty ingredients company, supplying taste, scent, and health solutions to food, beverage, personal care, pharmaceutical, and household goods manufacturers. The company generates approximately 50% of profits from taste and scent segments, where it holds market-leading positions, and 30% from health and biosciences, where it leads in probiotics and enzymes. A food ingredients business contributes the remaining profits and is slated for divestiture. IFF's proprietary formulations and customer-partnership model enable customized solutions across its diversified customer base.